It is unclear from our current study, which, if any of these effects, were direct results of reduced P2Y2 signaling in metabolic tissues, e.g., adipose or liver, or rather than general effects of reduced obesity and inflammatory sequelae. The gene discussed is P2RY2; the disease is Obesity.